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The Exon Junction Complex (EJC) plays a critical role in multiple posttranscriptional events, including
RNA subcellular localization, nonsense-mediated decay (NMD), and translation. We previously reported
that knockdown of the EJC core component Eukaryotic initiation factor 4a3 (Eif4a3) results in full-body
paralysis of embryos of the frog, Xenopus laevis. Here, we explore the cellular and molecular
mechanisms underlying this phenotype. We ﬁnd that cultured muscle cells derived from Eif4a3
morphants do not contract, and fail to undergo calcium-dependent calcium release in response to
electrical stimulation or treatment with caffeine. We show that ryr (ryanodine receptor) transcripts are
incorrectly spliced in Eif4a3 morphants, and demonstrate that inhibition of Xenopus Ryr function
similarly results in embryonic paralysis. These results suggest that the EJC mediates muscle cell
function via regulation of pre-mRNA splicing during early vertebrate embryogenesis.
& 2012 Elsevier Inc. All rights reserved.Introduction
RNA processing plays a fundamental role in the regulation of gene
expression (Moore and Proudfoot, 2009). Recent studies have impli-
cated the multi-protein Exon Junction Complex (EJC), which binds
upstream of exon splice junctions in a sequence-independent fashion,
in a number of RNA processing events, including localization, splicing,
translation, and degradation (Le Hir et al., 2001; Le Hir et al., 2000;
Tange et al., 2004). The EJC consists of several core proteins and
numerous accessory factors (Bono and Gehring, 2011; Moore and
Proudfoot, 2009); Eif4a3 is the EJC core component thought to
directly contact RNA (Ballut et al., 2005; Shibuya et al., 2004). Eif4a3
was ﬁrst identiﬁed in animal cells in a screen for transcripts
upregulated in the ventral ectoderm of gastrula stage Xenopus
embryos (Weinstein et al., 1997). Eif4a3 expression is quite dynamic
during subsequent stages of development, suggesting diverse, tissue-
restricted activities for this factor (Weinstein et al., 1997). Eif4a3
misexpression is sufﬁcient to drive epidermal induction in cells
otherwise destined to adopt a neural fate (Weinstein et al., 1997).
Loss-of-function studies suggest that the requirement for Eif4a3
during development is more nuanced: morpholino-mediated knock-
down of Eif4a3 leads to defects in heart looping and melanophore
development and, strikingly, complete embryonic paralysis
(Haremaki et al., 2010).
Although it is clear that Eif4a3 is essential for normal embryogen-
esis, the mechanisms underlying this requirement are not wellll rights reserved.
C. Weinstein).understood. Knockdown of the EJC core components Y14 and Magoh
give rise to defects similar to those seen in Eif4a3 morphants,
suggesting that the embryonic requirement for Eif4a3 is mediated
through its role in the EJC (Haremaki et al., 2010; Kenwrick et al.,
2004); however, the pleiotropic effects seen following Eif4a3 loss-of-
function may reﬂect the disruption of one or several distinct RNA
processing functions for this protein, acting on one or more target
transcripts.
In order to address the speciﬁc requirements for Eif4a3 during
development, we have focused on one aspect of the Eif4a3 morphant
phenotype: we describe here the cellular and molecular mechanisms
underlying the paralysis that results from Eif4a3 knockdown. We ﬁnd
that muscle cell cultures derived from Eif4a3 morphant embryos fail
to contract in response to electrical or chemical stimulation; this
appears to result from a defect in calcium-dependent calcium release.
We demonstrate that the Ryanodine receptor 1 (Ryr1), a keymediator
of intracellular calcium release, is required for embryonic movement
in Xenopus; furthermore, we show both that Ryr1 is dramatically
downregulated following Eif4a3 knockdown, and that ryr1 transcripts
are improperly spliced in Eif4a3 morphants. Our results thus impli-
cate Eif4a3 in muscle cell function, via regulation of ryr1 pre-mRNA
splicing.
Materials and methods
Eif4a3 constructs and morpholinos
For Myc–Eif4a3, the coding sequence of X. laevis eif4a3 was
ampliﬁed by PCR using the following primers: XEif4a3–5mycU:
AGGCCTGCGGCCGCAGCTGTTGCAG; XEif4a3–5mycD: AGGCCTCA
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(EQKLISEEDLNEM) epitopes in the StuI site of CS2þMT. X. laevis
Eif4a3 morpholino (Eif4a3MO) and the ﬁve-mismatch control
morpholino (MM) were described previously (Haremaki et al.,
2010). A construct containing only the coding sequence of X. laevis
Eif4a3 was described previously (Weinstein et al., 1997);
both this and the Myc–Eif4a3 construct lack the Eif4a3MO-
binding site.
Muscle cell culture
X. laevis muscle cell cultures were prepared as described
(Nacira Tabti, 1998). For electrical charge assays, cells were
stimulated directly by silver electrodes at 10 V, 20 V, or 200 V
6 Hz using an Isolated Pulse Stimulator (model# 2100, A-M
Systems). Immunocytochemistry for Xenopus muscle cell culture
was performed as described (Campbell et al., 2006). Anti-myosin
antibody (MF20, Developmental Studies Hybridoma Bank) was
used at 1:60 dilution; FITC-conjugated secondary antibody (Jackson
ImmunoResearch) was used at 1:50 dilution.
Calcium imaging
Stock solution (1 mM) of the membrane-permeant form of ﬂuo-4
(Invitrogen) was prepared in DMSO, then added to culture media to
give a ﬁnal concentration of 3 mM. The nonionic detergent Pluronic
F-127 (0.03% ﬁnal) was added to increase solubility (Prada et al.,
2005). Two days after culture preparation, cells were incubated with
ﬂuo-4 for 30 min at room temperature, then washed 3 times in
culture media. 10 V 6 Hz 2 s electrical stimulation was applied to the
cells; simultaneously, images of ﬂuo-4 treated cells were taken by 2 s
exposure using a Leica DMIL inverted microscope with ﬁlter module
I3 and a DFC420c camera, and analyzed by ImageJ.
Caffeine and ionomycin treatment
For caffeine treatment, stock solutions (300 mM) were diluted
into 62.5 mM in 1.2 mL of culture medium removed from the
cultured cells; this was then added back to the remaining 1.8 mL
medium. For ionomycin treatment, stock solutions (2 mM) were
diluted into 200 mM with PBS then added to culture medium at a
concentration of 1:100.
Ryanodine receptor genomic sequence and splice-blocking
morpholinos
X. laevis partial ryr1 cDNA sequence (Contig043167) was obtained
from XDB3.2 (http://xenopus.nibb.ac.jp/). To acquire ryr1 genomic
sequence, X. laevis genomic DNA was ampliﬁed by PCR using the
following primers: XlRYRprobeU: TCTGTCCATTCTGGGACACT,
XlRYRprobeD: GACCAGTGTGTTCCGTTTCA. The ampliﬁed
3.2 kb fragment was cloned into the T-vector (Promega) and fully
sequenced. Exon-intron structures were predicted by comparison
with Xenopus tropicalis ryr1 (JGI v4.1, ID: 469327). A splice-
blocking morpholino (RyrMO)(AGATAATGTTCTCTGACCTGTTTGC)
was designed at the exon 99-intron 99 boundary. The effects of
this morpholino on ryr1 transcripts were conﬁrmed by RT-PCR
using the following primers: XlRYRprobeU: TCTGTCCATTCTGG-
GACACT, RYRnewD: CAGCTCTCCAAATGCATCAA. The Ryr5MM
morpholino (AGAaAATcTTgTCTcACCTcTTTGC ) introduced 5 base
pair mismatches to the RyrMO sequence.
RNA co-immunoprecipitation (RIP) and RT-PCR
1 ng Myc–eif4a3 RNA was injected with and without 21 ng
Eif4a3MO into 2-cell stage embryos, which were subsequentlyharvested at stage 27. RNA co-immunoprecipitation assays were
performed as described (Vishnu et al., 2011). Precipitated RNA
was puriﬁed by RNA-Bee (Tel-Test, Inc.). After DNase treatment,
cDNA was synthesized with random hexamers by MMLV Reverse
Transcriptase (Promega). RT-PCR was performed as described
(Wilson and Hemmati-Brivanlou, 1995). Primers used in this
study are as follows:
Xlryr50F1: GAGGAGATCCAGTTCCTCAG,
Xlryr50R4: GAATAGCATGGCCATAGAGC,
RYRnewU: CTGGCCGTGGTTGTTTATCT,
RYRnewD: CAGCTCTCCAAATGCATCAA,
ProbeD: GACCAGTGTGTTCCGTTTCA,
RYRE101F: TGCTATCTCTTCCACATGTA (exon 101 primer),
RYRI101F: GAACCCGAAAATACCCCATC (intron 101 primer),
RYRE102R: CTCCATGTCCTCCTTTACTTG (exon 102 primer),
FoxD3U: TGTGGAGCGTAACTGGAATG,
FoxD3D: GTTCTTGGGCTTGTTCTGGA,
GSK3BP_U: TTCTTGCGTGAGGGGTAGAA,
GSK3BP_D: CATTGCACGGTTGTCTCAGT,
CYP1C_U: GCCCCATCTCACCTTTTGTA,
CYP1C_D: GAAGTCAAGCGCAGGAAAAC,
ODC-F: AATGGATTTCAGAGACCA,
ODC-R: CCAAGGCTAAAGTTGCAG.
Western blot analysis
Western blot analysis was performed as described (Hama
et al., 2002). Antibodies that detect both ryanodine receptor-1
and -2 isoforms (34C, Developmental Studies Hybridoma Bank)
were used at 1:50 dilution. Antibodies against b-Tubulin (T8660,
Sigma) were used at 1:200 dilution. Secondary antibodies (donkey
anti-mouse IgG coupled to horseradish peroxidase) (Jackson Immuno
Research) were used at 1:1,000 dilution.Results
Eif4a3 is required for muscle cell contraction
We previously reported that knockdown of the EJC component
Eukaryotic initiation factor 4a3 (Eif4a3) results in full-body
paralysis in embryos of the frog Xenopus laevis (Haremaki et al.,
2010). Paralysis can arise from a variety of causes, including
defects in skeletal muscle and/or neuronal development. Eif4a3
morphants have sensory neuron defects that may underlie the lack
of touch response in these embryos; however, this is not a likely
cause of paralysis (Haremaki et al., 2010). While we observed no
marked differences in somite structure between Eif4a3 morphants
and control embryos, we have not yet addressed directly the
effects of Eif4a3 knockdown on muscle cell activity.
To investigate the potential requirement for Eif4a3 in muscle
development and function, muscle cell cultures were prepared from
stage 23 dorsal explants of uninjected embryos, Eif4a3 morpholino
(Eif4a3MO)-injected embryos, or embryos injected with a control
morpholino that differs at 5 base pairs and does not affect Eif4a3
translation (Eif4a3MM) (Haremaki et al., 2010; Nacira Tabti, 1998).
Spindle-shaped cells obtained from control and morphant embryos
were morphologically indistinguishable; staining with the anti-
myosin speciﬁc antibody MF20 conﬁrmed that these were indeed
muscle cells (Fig. 1A)(Bader et al., 1982). To assess muscle cell
contractility, we subjected cultures to electrical stimulation
(Xie et al., 1997). All Eif4a3MM-injected spindle-shaped muscle
cultures tested contract in response to electrical stimulation of 20V
(100%; n¼34); muscle cultures derived from Eif4a3MO-injected
Fig. 1. Impaired contraction of Eif4a3 morphant muscle cell cultures. (A) Labeling of spindle-shaped cultured cells by the myosin-speciﬁc MF20 antibody. Cell shown in
middle panel was processed without primary antibody. Cells were derived from Eif4a3MO and Eif4a3MM (5MM) morphant embryos. (B) Eif4a3 knockdown inhibits
contraction of muscle cells in response to electrical stimulation. Muscle cell cultures were derived from stage 23 embryos injected with Eif4a3 morpholino (Eif4a3MO), ﬁve
base pair mismatch control morpholino (MM), or both Eif4a3MO and eif4a3 RNA (Rescue) (n¼25, 34, 25, respectively). Number of cells observed to contract, as a
percentage of the total, are shown. (C) Eif4a3 knockdown inhibits increase of intracellular calcium in muscle cells following electrical stimulation. Spindle shaped muscle
cells were obtained from stage 23 embryos injected with Eif4a3 morpholino (Eif4a3MO), ﬁve base pair mismatch control morpholino (MM), or both Eif4a3MO and eif4a3
RNA (Rescue) and incubated with the ﬂuorescent calcium indicator, ﬂuo-4. (D) Quantiﬁcation of studies shown in (C). Fluorescence intensity was compared before and
after 10 V electrical stimulation. Each of ﬁve cultures was measured and averages of fold change (after/before) were plotted. Error bars indicate S.D.
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tion (14%; n¼25) (Fig. 1B; also see video ﬁles). These latter cultures
also failed to contract in response to 200 V stimulation (0%; n¼12;
data not shown). Themorpholino effect was rescued by co-expression
of 1ng morpholino-insensitive eif4a3 RNA (76%; n¼25) (Haremaki
et al., 2010) (Fig. 1B). These results suggest that a defect in muscle
ﬁber contraction contributes to the Eif4a3 morphant paralysis
phenotype.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2012.08.013.
Eif4a3 is required for calcium release from the sarcoplasmic
reticulum
To investigate the basis for the lack of response to electrical
stimulation in Eif4a3-depleted cells, we used a membrane-permeant
form of ﬂuo-4, a calcium-sensitive ﬂuorescent dye, to compare
intracellular calcium levels in control and Eif4a3 morphant cultures.
Muscle cells from embryos injected with Eif4a3MM, Eif4a3MO, or
Eif4a3MO and eif4a3 RNA (‘‘Rescue’’) were treated with ﬂuo-4, andcalcium levels were measured following electrical stimulation.
A signiﬁcant increase in ﬂuorescence was observed in Eif4a3MM-
derived muscle cells following application of 10 V stimulation;
however, increases were not detected in Eif4a3MO-derived muscle
cells following stimulation (Fig. 1C and D). Eif4a3 RNA overexpression
rescued this effect (Fig. 1C and D). Taken together, these studies
suggest that Eif4a3 is required for normal intracellular calcium
release. We note that, while post-stimulation ﬂuorescence in the
Eif4a3MO, Eif4a3MM, and Rescue cells are indistinguishable, pre-
stimulation (baseline) ﬂuorescence is higher in the Eif4a3MO
(74.6711.0) than in the Eif4a3MM (49.7713.4) or Rescue cultures
(51.975.5)(data not shown); these data suggest that the diminished
response to electrical stimulation following Eif4a3 knockdown may
result, at least in part, from a leak in intracellular Ca2þ stores.
Eif4a3 is required for Ryanodine receptor expression
Ca2þ-induced Ca2þ release from the sarcoplasmic reticulum
(SR) is essential for muscle cell contraction; the Ryanodine
receptor 1(Ryr1) is a critical regulator of this process in skeletal
Fig. 3. Eif4a3 knockdown leads to a reduction in ryanodine receptor (ryr) RNA and
protein levels. (A) Semi-quantitative RT-PCR analysis of ryr (25 cycles); odc was
used as a loading control. RNA was puriﬁed from stage 27 embryos injected with
mismatch control morpholinos (MM), Eif4a3 morpholinos (Eif4a3MO), or co-
injected with Eif4a3MO and eif4a3 RNA (Rescue). (B) Western blot analysis with
anti-Ryr antibody (34C, Developmental Studies Hybridoma Bank). b-Tubulin,
visualized with an anti-b-Tubulin antibody, was used as an internal control.
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of Ryr1 in Eif4a3-mediated muscle cell contraction, we treated
muscle cells with the Ryr activator caffeine (Stephenson, 2008).
Cell contractions were observed in 81% of Eif4a3MM cultures
(n¼51) following treatment with 25 mM caffeine; in Eif4a3MO
muscle cultures, however, caffeine treatment did not induce
cell contraction (n¼32)(Fig. 2A and B). Addition of the calcium
ionophore ionomycin, however, induced muscle cell contractions
in 100% of Eif4a3MM cultures (n¼27) and 95% of Eif4a3MO
cultures (n¼20) (Fig. 2C and D). Taken together, these
results suggest that loss of Eif4a3 impairs contractility through
inhibition of calcium release, and may act via inhibition of Ryr
function.
To address this possibility, we examined ryrmRNA and protein
in stage 27 Eif4a3 morphants and control embryos. ryr1 mRNA
levels were reduced in Eif4a3-depleted embryos relative to
that seen in Eif4a3MM-injected controls; this effect was rescued
by co-expression of eif4a3 RNA (Fig. 3A). Ryr protein was clearly
detected in uninjected embryos, and in embryos injected
with Eif4a3MM; Ryr was reduced to undetectable levels in
Eif4a3 morphants (Fig. 3B and data not shown). This effect was
rescued by co-expression of eif4a3 RNA (Fig. 3B); Eif4a3 activity
thus appears to be required for expression of ryr1 mRNA and
protein.Fig. 2. Eif4a3 morphant muscle cells are insensitive to caffeine, and contract in respo
mediated contraction in muscle cell cultures. Muscle cells were prepared from Eif4a3MM
(B) Graph summarizing caffeine experiment results. (C) Ionomycin induces contractility
from Eif4a3MM (MM)- or Eif4a3MO-injected stage 23 embryos and treated with 2 mMThe ryanodine receptor is required for embryonic movement
To directly investigate the role of the Ryanodine receptor in
muscle contraction in X. laevis, we utilized a splice-blocking Ryrnse to the calcium ionophore ionomycin. (A) Eif4a3 knockdown inhibits caffeine-
(MM)- or Eif4a3MO-injected stage 23 embryos and treated with 25 mM caffeine.
in both wild-type and Eif4a3 morphant cell cultures. Muscle cells were prepared
ionomycin. (D) Graph summarizing ionomycin experiment results.
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tive exon-intron boundary 99 of X. laevis ryr1 (Fig. 4A). As
expected, PCR and sequence analysis demonstrated that the
target intron is retained in RyrMO-injected, but not in uninjected
embryos or embryos injected with a control morpholino that
differs from RyrMO at 5 base pairs (Ryr5MM)(Fig. 4B, and data not
shown). Western blot analysis with anti-Ryr antibody showed a
strong decrease in Ryr protein following injection of RyrMO, but
not Ryr5MM, in stage 27 embryos (Fig. 4C). Injection of RyrMO,
but not Ryr5MM, results in complete paralysis in stage 27
embryos (n¼23)(Fig. 4D). These data further support our hypoth-
esis that Ryanodine receptor inhibition underlies the paralysis
observed in Eif4a3 morphants.
The vertebrate ryr genes code for proteins of approximately
5000 amino acids (Zalk et al., 2007). No full-length ryr cDNAs
have been isolated from X. laevis or X. tropicalis; transcript size in
the latter organism is predicted to exceed 15 Kb (JGI v.4.1 ID:Fig. 4. Ryr is required for embryonic movement in X. laevis. (A) Schematic showing th
expected PCR product size with indicated primers (arrows). (B) RT-PCR analysis of stage
(Ryr5MM). (C) Western blot analysis using an anti-Ryr antibody. b-Tubulin was used
embryos. Graph depicting percentage of touch-unresponsive stage 27 embryos injec
movement at later stages (data not shown). Control embryos were injected with 20 ng R
Ryr5MM, RyrMO and Eif4a3MO-injected embryos at stage 32.469327). We have not successfully generated full-length ryr RNA
in vitro from any species; thus, we have not been able to test
directly whether Ryr is epistatic to Eif4a3 in the context of
embryonic movement. We previously reported that Eif4a3 is also
required for embryonic pigmentation and cardiac looping
(Haremaki et al., 2010); RyrMO-injected embryos, in contrast,
do not display pigmentation or cardiac defects, suggesting that
the developmental requirement for Eif4a3 is not mediated solely
through Ryr (Fig. 4E and data not shown).
Eif4a3 is required for accurate splicing of the ryanodine receptor
pre-mRNA
RT-PCR analysis of the ryanodine receptor 1 transcript revealed
several larger-than-expected PCR products following Eif4a3 knock-
down (Fig. 5A and B). Interestingly, sequence analysis revealed that
larger products contain ryanodine receptor intronic sequences: PCRe binding site for the Ryr splice-blocking morpholino (RyrMO); numbers indicate
27 embryos injected with either RyrMO or a 5 base pair mismatch Ryr morpholino
as a loading control. (D) Ryr knockdown leads to complete paralysis in Xenopus
ted with 20 ng RyrMO/embryo (n¼23); these animals showed no spontaneous
yr5MM/embryo, and were largely responsive to touch (n¼17). (E) Uninjected (UI),
Fig. 5. Eif4a3 is required for correct splicing of ryanodine receptor (ryr) pre-mRNA. (A) RT-PCR analysis of ryr RNA from Eif4a3MM (5MM) and Eif4a3MO-injected stage 27
embryos; primer pairs are indicated in (B). 29 cycles of PCR was used for this analysis, and samples were not normalized. (B) (a) Intron-exon conﬁguration of the X. laevis
ryanodine receptor gene from exons 100 to 104. Exons and introns are represented by boxes and lines, respectively; exon size is given in boxes and intron size is given
above lines. Exon number is indicated above the boxes, and is based on the X. tropicalis ryr sequence. (b) Expected RT-PCR product after complete splicing. (C) Observed
retention patterns of introns 101 and 103. PCR products from Eif4a3MO-injected embryos that were larger than 487 bp were cloned and sequenced. The schematic shows
the four identiﬁed retention patterns of intron 101. For intron 103, only complete retention was observed. The size of each intron subdomain is indicated. Sequences of
exon-intron and intron subdomain boundaries are indicated.
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intron 101, or with complete retention of intron 103. Notably, a
mutation in the region of mammalian ryr corresponding to Xenopus
exon 101 leads to a severe form of central core disease in humans,
and inhibition of Ca2þ release in the mouse (Zvaritch et al., 2007).
Retention of introns 100 or 102 were not observed (Fig. 5C and data
not shown). All partially retained introns include the sequences ‘‘TT’’
‘‘AG’’ at their 50 and 30 termini, respectively. For these studies, only the
C-terminal-encoding sequence of Xenopus ryr1 was available for
analysis; therefore, there may be Eif4a3 knockdown-dependent
splicing defects in other parts of the transcript that were not
identiﬁed here. Nevertheless, our data demonstrate that Eif4a3 is
required for correct splicing of the ryr1 transcript.
To determine the fraction of ryr mRNA that is aberrantly
spliced following Eif4a3 knockdown, we analyzed wild-type and
Eif4a3 morphant embryos derived from ﬁve different frogs,
comparing the relative levels of exon 101-exon 102 and intron
101-exon 102 products generated under each condition, using
semi-quantitative RT-PCR and primers speciﬁc to each region. In
wild-type embryos, the intron-exon (‘‘incorrectly spliced’’) pro-
duct was virtually non-existent; in Eif4a3 morphants, however,
the intron-exon product averaged 41.4716.4% of the ryr total
(exon101-exon102 and intron101-exon102), on a molar basis
(data not shown). This analysis takes into account only intron
101 retention; the total incorrectly spliced ryr fraction following
Eif4a3 knockdown may thus be signiﬁcantly higher than
reported here.
Eif4a3 binds to ryanodine receptor mRNA
Our studies implicate Eif4a3 in ryr splicing ﬁdelity, suggesting
the potential for direct association between Eif4a3 and the ryrtranscript (Ballut et al., 2005; Shibuya et al., 2004). To address this
possibility, we injected early cleavage stage embryos with RNA
encoding Myc epitope-tagged eif4a3, and performed immunopre-
cipitations with an anti-Myc antibody at stage 27. Reverse
transcription, followed by PCR using primers against 50 and 30
exonic regions of ryr, were used to amplify co-precipitated ryr
RNA. We ﬁnd that ryr is present in anti-Myc-immunoprecipitated
samples, but not in control samples in which IgG was substituted
for anti-Myc antibody (Fig. 6A). This trend was even more
apparent when native Eif4a3 was depleted by co-injection of
Eif4a3MO (Fig. 6B). The EJC has been shown to bind RNA
upstream of exon-exon boundaries (Le Hir et al., 2001; Le Hir
et al., 2000); we therefore used the transcripts of intronless genes
as negative controls in this study; as expected, PCR products of
cDNA derived from the intronless genes gbp, cyp1c and foxd3 were
not detected in immunoprecipitated samples (Fig. 6A and B).
These results indicate that Eif4a3 can bind ryr mRNA, and
supports a model in which Eif4a3 regulates embryonic movement
via proper splicing of ryr pre-mRNA.Discussion
Eif4a3 is essential for normal embryonic development, and
has been implicated, as a component of the multi-protein EJC,
in multiple RNA processing events (Haremaki et al., 2010; Tange
et al., 2004). We ﬁnd that Eif4a3 is required for the contraction of
cultured muscle cells and mediates the proper splicing of ryr1,
knockdown of which leads to complete embryonic paralysis, a
phenotype we previously observed following knockdown of the
EJC components Eif4a3, Y14, or Magoh (Haremaki et al., 2010).
Taken together, our studies suggest that Eif4a3, via the actions of
Fig. 6. Eif4a3 associates with ryr mRNA. Cell extracts from stage 27 embryos
injected with Myc–Eif4a3 (A) or Myc–Eif4a3 with Eif4a3MO (B) were incubated
overnight with anti-Myc antibody or mouse IgG. Following immunoprecipitation,
Myc–Eif4a3-associated RNA was puriﬁed, reverse transcribed, and ampliﬁed using
gene-speciﬁc primers. ‘‘Input RNA’’: non-immunoprecipitated RNA.
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as a result, for Ryr function, muscle cell contraction, and embryo-
nic movement.
While we predict that aberrant splicing of ryr contributes to a
loss of embryonic mobility via effects on muscle cell contractility,
mammalian ryr1 has been shown to be required for calcium release
in neuronal populations, as well (de Crescenzo et al., 2012). Ryr
dysregulation in neuronal tissue may thus also contribute to the
Eif4a3 morphant phenotype. Efforts are underway to determine
whether neuronal defects observed in Eif4a3 morphants are
mediated by Ryr loss-of-function (Haremaki et al., 2010).
During the course of these studies, two papers were published
demonstrating a requirement for Eif4a3 in the splicing of the
Drosophila ERK MAP kinase transcript (Ashton-Beaucage et al.,
2010; Roignant and Treisman, 2010). In these studies, whole-
genome analyses were used to demonstrate that only a small
subset of transcripts are affected by Eif4a3 loss-of-function; those
with large introns are particularly sensitive to splicing defects
(Ashton-Beaucage et al., 2010; Roignant and Treisman, 2010). The
apparently normal early development of Xenopus Eif4a3 mor-
phants suggests that many splicing events are unaffected by loss
of Eif4a3 during vertebrate embryogenesis, as well (Haremaki
et al., 2010). It will be interesting to determine whether intron
size or number correlates with Eif4a3-dependent splicing in
Xenopus. We have not observed alterations in ERK splicing in
Eif4a3 morphants, despite the fact that ERK, based on the
predicted Xenopus tropicalis genomic structure, includes a 19 Kb
intron (JGI v.4.1, ID 155435) (data not shown). We have yet to
examine all eight predicted introns in Xenopus ERK, however, and
our studies do suggest a differential sensitivity among Xenopus ryr
introns to Eif4a3 knockdown (Fig. 5). Establishment of the
distinguishing features of Eif4a3-regulated transcripts and introns
in Xenopus will be an important step in deﬁning the mechanisms
by which Eif4a3 and the EJC regulate pre-mRNA splicing in the
vertebrate embryo.
Eif4a3 knockdown leads to defects in ryr splicing, and
a reduction of Ryr, in vivo; Eif4a3 knockdown may also lead,
via alternative splicing, to the production of distinct Ryr isoforms
that contribute to embryonic paralysis or other phenotypes seen
in the Eif4a3 morphants. Alternative splicing has been shown to
play important roles during embryogenesis including, for exam-
ple, in Drosophila sex determination (Salz, 2011). Recent studies in
human embryonic stem (ES) and induced pluripotent stem (iPS)
cells have demonstrated, remarkably, that alternative splicing ofFOXP1 produces two proteins with distinct DNA binding speciﬁ-
cities that together regulate the transcriptional network govern-
ing stem cell pluripotency and differentiation (Gabut et al., 2011).
Loss of EJC components, including Eif4a3, has recently been
shown to promote the production of proapoptotic splice variants
of several Bcl family members in cultured cell lines, demonstrat-
ing that Eif4a3 can regulate alternative splicing in vitro (Michelle
et al., 2012). Studies are in progress to address whether Eif4a3
knockdown also generates alternative splice variants of ryr that
possess biological activity.
Our studies implicate splicing dysregulation as a primary
mechanism underlying paralysis in Eif4a3 morphants; they do
not, however, preclude distinct requirements for Eif4a3 in other
regulatory mechanisms during embryogenesis, nor do they elim-
inate the possibility that ryr splicing defects are an indirect
consequence of Eif4a3 loss-of-function. Future studies will
address whether Eif4a3 knockdown-mediated defects in melano-
phore and cardiac development are a result of errors in NMD,
splicing, and/or other RNA processing events.Acknowledgments
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